parsabiv
amgen europe b.v. - etelcalcetide hydrochloride - hiperparatiroidismo, secundario - anti-parathyroid agents, calcium homeostasis - parsabiv está indicado para el tratamiento del hiperparatiroidismo secundario (shpt) en pacientes adultos con enfermedad renal crónica (erc) en terapia de hemodiálisis.
parsabiv solución inyectable 5 mg/1 ml (etelcalcetida)
tecnofarma s.a. - etelcalcetida - sin formulas
parsabiv 10 mg 6 vials injectables 2 ml
parsabiv 2.5 mg 6 vials injectables 0.5 ml
parsabiv 5 mg 6 vials injectables 1 ml
libmeldy
orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - otras drogas del sistema nervioso - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still have the ability to walk independently and before the onset of cognitive decline.
ceftiofur arsa antibiótico
arsa - bovinos; porcinos;
solarsal 0,05 % solucion atomizador nasal
biotech laboratorios, c.a. - oximetazolina clorhidrato - solucion - 0,05 %
solarsal 0,025 % solucion nasal
biotech laboratorios, c.a. - oximetazolina clorhidrato - solucion - 0,025 %